Northwell Holdings — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Health Note provides a voice AI system for medical practices and health systems that answers patient phone calls, schedules appointments, handles patient intake and insurance verification, processes medication refills, and generates clinical notes.
AI & Machine LearningDigital HealthHealthtech
Joshua Reischer(Co-founder (physician))inAaron Rau(Co-founder)in
Co-investorsAfore CapitalCeltic House Asia PartnersDreamit VenturesFounder CollectiveRange VCSignalFire+2 more
Violet Labs builds software tools for engineers designing and building physical products across industries including aerospace, defense, robotics, and energy.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareHardware
Lucy Hoag(Founder)in
Co-investorsFelicis VenturesMaC Venture CapitalV1 VCDementia Discovery FundHopelabOno Venture Investment, Inc.+2 more
Violet provides free, personalised support for Australian families navigating end-of-life care, combining human connection and technology to offer practical guidance, emotional support, and tools for important conversations.
Digital HealthFintechHealthtechImpact & Social GoodMental HealthHaymarket, AU
BoardKate Carnell(Chairperson)
Co-investorsTechstarsDementia Discovery FundHopelabOno Venture Investment, Inc.The Venture CollectiveUTEC
Violet provides healthcare organizations with data analytics and tools to measure and improve their ability to deliver person-centered care that considers patients' individual preferences, identities, and experiences.
Data & InfrastructureDigital HealthHealthtechNew York City, US
Gaurang Choksi(CEO and Founder)inScott Zaloom(Head of Operations)inDr. Kay Nikiforova(Head of Clinical & Research)inEliot Kristan(Head of Engineering)in
Co-investorsSeae VenturesSemperVirens Venture CapitalThe Venture CollectiveW Health Ventures Gp LlcDementia Discovery FundHopelab+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.